PASW vs REBN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
PASW presents a classic 'value trap' scenario, characterized by a stable Piotroski F-Score of 5/9 but catastrophic operational decay. While the balance sheet remains relatively clean with low debt and a healthy current ratio, the company has suffered a massive 62% year-over-year revenue collapse and negative profit margins. The 95% decline in share price over the last year reflects a fundamental breakdown in the business model, which is not offset by the low Price-to-Book ratio of 0.51.
REBN exhibits critical financial instability, characterized by a Piotroski F-Score of 4/9 and the absence of a calculable Altman Z-Score or Graham Number due to negative equity. The company is facing a severe liquidity crisis with a current ratio of 0.08, indicating an inability to meet short-term obligations. While gross margins are healthy at 55.51%, massive operating losses (-224.67% margin) and negative book value (P/B -4.66) suggest a high risk of insolvency. Recent short-term price gains appear speculative and are not supported by fundamental improvements.
Compare Another Pair
Related Comparisons
PASW vs REBN: Head-to-Head Comparison
This page compares Ping An Biomedical Co., Ltd. (PASW) and Reborn Coffee, Inc. (REBN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.